[go: up one dir, main page]

EA200601158A1 - Комбинация ингибитора обратного захвата серотонина и антагониста, обратного агониста или частичного агониста рецептора гистамина 3 - Google Patents

Комбинация ингибитора обратного захвата серотонина и антагониста, обратного агониста или частичного агониста рецептора гистамина 3

Info

Publication number
EA200601158A1
EA200601158A1 EA200601158A EA200601158A EA200601158A1 EA 200601158 A1 EA200601158 A1 EA 200601158A1 EA 200601158 A EA200601158 A EA 200601158A EA 200601158 A EA200601158 A EA 200601158A EA 200601158 A1 EA200601158 A1 EA 200601158A1
Authority
EA
Eurasian Patent Office
Prior art keywords
disorders
agonist
disorder
antagonist
anxiety
Prior art date
Application number
EA200601158A
Other languages
English (en)
Inventor
Томас Иво Франсискус Хуберт Кремерс
Виллигерс Сандра Хогг
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2004/000862 external-priority patent/WO2005056056A2/en
Publication of EA200601158A1 publication Critical patent/EA200601158A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к применению соединения, которое является ингибитором обратного захвата серотонина, и другого соединения, которое является антагонистом, обратным агонистом или частичным агонистом рецептора Ндля получения фармацевтической композиции для лечения депрессии, тревожных расстройств и других аффективных расстройств, таких как генерализованное тревожное расстройство, паническая тревога, обсессивно-компульсивное расстройство, острое стрессовое расстройство, посттравматическое стрессовое расстройство и социальное тревожное расстройство, пищевые расстройства, такие как булимия, анорексия и ожирение, фобии, дистимия, предменструальный синдром, когнитивные расстройства, расстройства импульсивной регуляции, гиперактивные расстройства с дефицитом внимания, злоупотребление лекарственными средствами или любые другие расстройства, отвечающие на ингибитор обратного захвата серотонина.
EA200601158A 2003-12-15 2004-12-14 Комбинация ингибитора обратного захвата серотонина и антагониста, обратного агониста или частичного агониста рецептора гистамина 3 EA200601158A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301854 2003-12-15
PCT/DK2004/000862 WO2005056056A2 (en) 2003-12-15 2004-12-14 The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist

Publications (1)

Publication Number Publication Date
EA200601158A1 true EA200601158A1 (ru) 2006-10-27

Family

ID=36608817

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601158A EA200601158A1 (ru) 2003-12-15 2004-12-14 Комбинация ингибитора обратного захвата серотонина и антагониста, обратного агониста или частичного агониста рецептора гистамина 3

Country Status (9)

Country Link
US (1) US20070066601A1 (ru)
KR (1) KR20060124639A (ru)
CN (1) CN1893935A (ru)
AR (1) AR048134A1 (ru)
CA (2) CA2643922A1 (ru)
EA (1) EA200601158A1 (ru)
IL (1) IL176238A0 (ru)
IS (1) IS8388A (ru)
ZA (1) ZA200603397B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704527B2 (en) * 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20080182898A1 (en) * 2007-01-23 2008-07-31 Ampla Pharmaceuticals Inc. Treatment of metabolic syndrome with norfluoxetine
EP3773556A1 (en) * 2018-04-05 2021-02-17 Frequency Therapeutics, Inc. Compositions and methods for increasing remyelination
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN114652671A (zh) * 2020-12-23 2022-06-24 上海博志研新药物技术有限公司 维拉佐酮药物组合物、其制备方法及应用
WO2025018810A1 (ko) * 2023-07-18 2025-01-23 주식회사 지오비스타 동물에 대한 정신질환 또는 행동장애의 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585731A2 (en) * 2002-09-18 2005-10-19 Eli Lilly And Company Histamine h3 receptor antagonists, preparaton and therapeutic uses
FR2856596B1 (fr) * 2003-06-27 2007-04-27 Bioprojet Soc Civ Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes.
US20060069087A1 (en) * 2004-09-27 2006-03-30 Pfizer Inc Histamine-3 receptor antagonists
CA2594487A1 (en) * 2005-01-19 2006-07-27 Matthias Heinrich Nettekoven 5-aminoindole derivatives

Also Published As

Publication number Publication date
IS8388A (is) 2006-03-30
AR048134A1 (es) 2006-04-05
CA2549574A1 (en) 2005-06-23
CN1893935A (zh) 2007-01-10
CA2643922A1 (en) 2005-06-23
ZA200603397B (en) 2007-09-26
US20070066601A1 (en) 2007-03-22
IL176238A0 (en) 2006-10-05
KR20060124639A (ko) 2006-12-05

Similar Documents

Publication Publication Date Title
DK1237553T3 (da) Kombination af en serotoningenoptagningshæmmer og en 5-HT2C antagonist, omvendt agonist eller partiel agonist
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EP1749818A3 (en) Phenyl-piperazine derivatives as serotonin reuptake inhibitors
ATE454372T1 (de) Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
ATE538650T1 (de) Cannabinoid-rezeptor-antagonisten / inverse agonisten zur behandlung von übergewicht
ATE556060T1 (de) Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
EA200500616A1 (ru) Замещенные производные 1,4-дипиперидин-4-илпиперазина и их применение в качестве нейрокининовых антагонистов
UA82828C2 (en) The use of enantiomeric pure escitalopram for treatment of depression
ATE357920T1 (de) Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers
EA200601158A1 (ru) Комбинация ингибитора обратного захвата серотонина и антагониста, обратного агониста или частичного агониста рецептора гистамина 3
EA200601220A1 (ru) Анти-trkc антитела-агонисты и способы их применения
WO2005056056A3 (en) The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
DK1381613T3 (da) Antidepressive azaheterocyclylmethylderivater af oxaheterocyclokondenserede 1,4-benzodioxaner
DK1399438T3 (da) Hidtil ukendte heteroarylderivater samt fremstilling og anvendelse heraf
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
DK1635828T3 (da) 4-(2-phenyloxyphenyl)-piperidin- eller -1,2,3,6-tetrahydropyridinderivater som serotoningenoptagelseshæmmere
EA200500770A1 (ru) Конденсированные гетероциклические соединения
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
DE60229123D1 (de) Behandlung von fibromyalgie mit pindolol
EA200600453A1 (ru) Комбинация ингибитора обратного захвата серотонина и ингибитора переносчика глицина типа 1 для лечения депрессии
ATE323094T1 (de) Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen
EA200401468A1 (ru) Комбинированное лечение с использованием ингибитора обратного захвата серотонина
EA200870052A1 (ru) Фармацевтические препаративные формы эсциталопрама модифицированного и пульсирующего высвобождения
EA201001799A1 (ru) Новые способы получения пиперазинильных и диазепанильных производных бензамида
EA201170034A1 (ru) Фторзамещенные производные 3,4-диарил-4,5-дигидро-1h-пиразол-1-карбоксамидина, имеющие активность антагониста cb